NASDAQ:AVXL
Anavex Life Sciences Corp.
- Stock
Last Close
4.50
17/05 20:00
Market Cap
511.70M
Beta: 0.75
Volume Today
942.30K
Avg: 1.09M
PE Ratio
−8.31
PFCF: −16.52
Sep '13 | Sep '14 | Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -1.32M - | -1.32M 0% | ||||||||||
average payables | 1.76M - | 3.76M 113.22% | 4.36M 16.19% | 4.28M 1.88% | 4.07M 4.88% | |||||||
average receivables | 38.42K - | 78.09K 103.26% | 44.55K 42.96% | 24.96K 43.97% | 1.34M 5,274.54% | 3.75M 179.25% | 6.99M 86.68% | 6.16M 11.85% | 2.95M 52.13% | |||
book value per share | -0.31 - | 0.02 106.36% | 0.69 3,408.08% | 0.18 73.96% | 0.59 230.94% | 0.46 22.73% | 0.41 9.59% | 0.47 12.81% | 2.16 361.65% | 1.85 14.25% | 1.78 4.04% | |
capex per share | -0.00 - | |||||||||||
capex to depreciation | -3.93 - | |||||||||||
capex to operating cash flow | 0.00 - | |||||||||||
capex to revenue | ||||||||||||
cash per share | 0.04 - | 0.74 1,612.26% | 0.82 11.08% | 0.26 68.24% | 0.67 157.10% | 0.51 23.57% | 0.45 11.66% | 0.50 10.80% | 2.18 333.56% | 1.94 11.00% | 1.89 2.40% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.54 - | 0.80 50.01% | 0.01 99.31% | |||||||||
debt to equity | -0.09 - | 30.69 35,951.35% | 0.01 99.98% | |||||||||
dividend yield | ||||||||||||
earnings yield | -0.18 - | -1.58 783.09% | -0.12 92.67% | -0.12 0.03% | -0.08 31.07% | -0.15 90.29% | -0.17 12.31% | -0.10 41.67% | -0.03 69.52% | -0.06 99.79% | -0.09 50.33% | |
enterprise value | 20.61M - | 5.87M 71.53% | 89.61M 1,427.72% | 118.42M 32.15% | 141.64M 19.61% | 92.28M 34.85% | 132.36M 43.43% | 235.54M 77.95% | 1.10B 367.38% | 644.55M 41.45% | 371.58M 42.35% | |
enterprise value over ebitda | -9.64 - | -0.51 94.75% | -7.40 1,363.02% | -7.87 6.37% | -9.10 15.56% | -4.82 47.00% | -4.58 4.97% | -7.58 65.45% | -26.41 248.34% | -12.87 51.27% | -7.82 39.21% | |
ev to operating cash flow | -26.50 - | -2.21 91.68% | -21.20 861.15% | -12.82 39.53% | -15.71 22.52% | -7.33 53.31% | -7.14 2.59% | -11.06 54.88% | -36.23 227.45% | -26.59 26.60% | -13.37 49.71% | |
ev to sales | ||||||||||||
free cash flow per share | -0.10 - | -0.27 178.58% | -0.23 16.24% | -0.26 15.53% | -0.22 15.97% | -0.28 27.62% | -0.38 34.45% | -0.37 3.44% | -0.44 19.00% | -0.32 27.60% | -0.35 10.50% | |
free cash flow yield | -0.04 - | -0.37 884.11% | -0.04 89.07% | -0.07 79.50% | -0.05 26.32% | -0.11 104.78% | -0.12 9.77% | -0.08 32.94% | -0.02 69.84% | -0.03 25.93% | -0.05 74.10% | |
graham net net | -0.31 - | 0.01 103.28% | 0.68 6,510.06% | 0.17 74.77% | 0.58 239.18% | 0.43 26.89% | 0.36 14.77% | 0.44 20.73% | 2.12 382.88% | 1.84 13.42% | 1.76 4.16% | |
graham number | 1.80 - | 0.72 60.12% | 3.18 343.98% | 1.30 59.07% | 2.10 61.30% | 2.01 4.27% | 2.24 11.52% | 2.18 2.66% | 5.14 135.62% | 5.10 0.75% | 4.88 4.31% | |
income quality | 0.21 - | 0.23 11.31% | 0.35 49.24% | 0.63 79.54% | 0.67 6.88% | 0.72 7.61% | 0.70 2.26% | 0.81 14.96% | 0.80 1.05% | 0.51 36.97% | 0.58 15.78% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -41.55 - | -418.81 908.09% | -98.97 76.37% | -1.31 98.67% | -57.44 - | -49.27 14.22% | ||||||
interest debt per share | 0.03 - | 0.60 1,736.62% | 0.01 98.60% | 0.32 3,702.97% | 0.01 - | 0.01 1.87% | ||||||
inventory turnover | ||||||||||||
invested capital | -0.09 - | 30.69 35,951.35% | 0.01 99.98% | |||||||||
market cap | 20.74M - | 7.22M 65.21% | 104.82M 1,352.55% | 127.61M 21.74% | 169.08M 32.50% | 115.21M 31.86% | 154.54M 34.14% | 264.79M 71.33% | 1.25B 373.20% | 793.71M 36.65% | 522.61M 34.16% | |
net current asset value | -2.46M - | 190.38K 107.73% | 12.81M 6,627.50% | 6.26M 51.16% | 24.20M 286.87% | 20.44M 15.55% | 20.29M 0.73% | 27.24M 34.24% | 150.82M 453.73% | 142.49M 5.52% | 141.85M 0.45% | |
net debt to ebitda | 0.06 - | 0.12 85.45% | 1.26 978.35% | 0.61 51.37% | 1.76 188.57% | 1.20 32.02% | 0.77 35.90% | 0.94 22.57% | 3.65 287.59% | 2.98 18.39% | 3.18 6.76% | |
net income per share | -0.46 - | -1.16 149.98% | -0.65 43.81% | -0.42 35.66% | -0.33 21.38% | -0.39 18.59% | -0.54 37.56% | -0.45 16.01% | -0.54 20.26% | -0.62 14.87% | -0.60 4.58% | |
operating cash flow per share | -0.10 - | -0.27 178.26% | -0.23 16.15% | -0.26 15.53% | -0.22 15.97% | -0.28 27.62% | -0.38 34.45% | -0.37 3.44% | -0.44 19.00% | -0.32 27.60% | -0.35 10.50% | |
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -9.40 - | -1.55 83.56% | -0.78 49.37% | -1.55 98.22% | -0.48 68.83% | -0.72 48.08% | -1.04 44.99% | -0.76 26.71% | -0.23 69.17% | -0.31 33.95% | -0.31 2.09% | |
revenue per share | ||||||||||||
roe | 1.50 - | -59.02 4,028.96% | -0.95 98.40% | -2.34 147.14% | -0.55 76.24% | -0.85 53.47% | -1.30 52.16% | -0.96 25.55% | -0.25 73.95% | -0.34 33.96% | -0.33 0.57% | |
roic | 0.96 - | -0.49 150.69% | -0.55 13.95% | -2.36 326.11% | -0.64 72.77% | -0.94 46.09% | -1.42 51.20% | -1.13 20.49% | -0.28 75.23% | -0.38 37.40% | -0.33 12.96% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | -0.31 - | 0.02 106.36% | 0.69 3,408.08% | 0.18 73.96% | 0.59 230.94% | 0.46 22.73% | 0.41 9.59% | 0.47 12.81% | 2.16 361.65% | 1.85 14.25% | 1.78 4.04% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | -2.46M - | 192.63K 107.82% | 12.81M 6,549.68% | 6.31M 50.75% | 24.25M 284.49% | 20.49M 15.51% | 20.29M 0.98% | 27.24M 34.24% | 150.82M 453.73% | 142.49M 5.52% | 141.85M 0.45% | |
tangible book value per share | -0.31 - | 0.02 106.36% | 0.69 3,408.08% | 0.18 73.96% | 0.59 230.94% | 0.46 22.73% | 0.41 9.59% | 0.47 12.81% | 2.16 361.65% | 1.85 14.25% | 1.78 4.04% | |
working capital | -1.56M - | 5.91M 479.04% | 12.81M 116.71% | 6.26M 51.16% | 24.20M 286.87% | 20.44M 15.55% | 20.29M 0.73% | 27.24M 34.24% | 150.82M 453.73% | 142.49M 5.52% | 141.85M 0.45% |
All numbers in USD (except ratios and percentages)